Jenny Norlin

3PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Apr 13, 2026
Therapeutic efficacy, biomarker signatures, and translatability of semaglutide in the liver biopsy-confirmed GAN DIO-MASH mouse model.

Jens Bjelke Kristensen, Jacob Nøhr-Meldgaard, Susanne E Pors

|Jul 21, 2025
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis.

Maximilian Jara, Jenny Norlin, Mette Skalshøi Kjær

|Oct 03, 2024
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.

Paul Horn, Jenny Norlin, Kasper Almholt

Pageof 1

Frequent Collaborators

2 joint publications

Kasper Almholt

2 joint publications

Lea M Harder

1 joint publications

Paul Horn

1 joint publications

Svend Poulsen

1 joint publications

Marco R Rink

1 joint publications

Chris J Weston

1 joint publications

Philip N Newsome

1 joint publications

Mette Skalshøi Kjær

1 joint publications

Lise L Gluud

1 joint publications

Gianluca Mazzoni

Frequent Collaborators

2 joint publications

Kasper Almholt

2 joint publications

Lea M Harder

1 joint publications

Paul Horn

1 joint publications

Svend Poulsen

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on : Apr 16, 2019

12.9K
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on : Jul 18, 2025

1.2K
See more related videos

Top Related Videos

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on : Apr 16, 2019

12.9K
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on : Jul 18, 2025

1.2K
See more related videos